migraine headache. Migraine without aura [common migraine]
Conditions
Interventions
Intervention 1: intervention group:existing standard drug with positional release techniquedrug:Propranololdosage:60mg(20mg in form of 3 in day)in 1st month,80-120mg in 2nd month keeping on up to reco
Treatment - Other
Treatment - Drugs
intervention group:existing standard drug with positional release techniquedrug:Propranololdosage:60mg(20mg in form of 3 in day)in 1st month,80-120mg in 2nd month keeping on up to recovery.if the drug
control group: existing standard drug drug:Propranolol dosage:60mg(20mg in form of 3 in day)in 1st month,80-120mg in 2nd month keeping on up to recovery.if the drug doesn't have effect,using drug woul
Sponsors
Shiraz university of medical science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: having migraine headache and at least one trigger point in upper trapezius,sternocloidomastoid,sub occipitals,multifidus,rotators and inter spinalis-having periodical attacks in given temporal range that according to the patient affect on daily activity considerably.-cases of contriandications,non influense or over use of pharmacologic symptom therapy-using of pharmacologic treatment for acute headache over twice in a week exclusion criteria: unusual migraine conditions such as hemiplegic migraine,basilar migraine,migraine with long time aura and infarctions of migraine-use of anti stress and anti depression drug,smoking,myastenia gravis,complete obstruction of heart vessels-second grade obstruction of Atrioventricular valve-weak sinus syndrome-wolf parkinson white syndrme-sinosoidal brady cardia-acute and serius heart failure symptoms-chronic bronchitis-pulmunary amphism-chronic pulmunary obstruction disease-broncho spasm-liver failure-kidney failure-blood circulation failure-pregnancy-diabetic melitus-low blood sugar
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache intensity. Timepoint: before intervention,2 weeks after begining of intervention,1 month after begining of intervention,2 months after begining of intervention,6 months after begining of intervention. Method of measurement: questionare.;Headache duration. Timepoint: before intervention,2 weeks after begining of intervention,1 month after begining of intervention,2 months after begining of intervention,6 months after begining of intervention. Method of measurement: questionare.;Headache frequency. Timepoint: before intervention,2 weeks after begining of intervention,1 month after begining of intervention,2 months after begining of intervention,6 months after begining of intervention. Method of measurement: questionare.;Threshold of pain. Timepoint: before intervention,2 weeks after begining of intervention,1 month after begining of intervention,2 months after begining of intervention,6 months after begining of intervention. Method of measurement: pressure algometr device.;Cervical range of motion. Timepoint: before intervention,2 weeks after begining of intervention,1 month after begining of intervention,2 months after begining of intervention,6 months after begining of intervention. Method of measurement: goniameter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaghar Askarzadeh
Shiraz university of medical science,rehabilitation school
Outcome results
None listed